Ascorbic Acid (Vitamin C) VC is supplied as a white to off-white crystalline powder under the product model VC-100. The material is identified by CAS 50-81-7, EINECS 200-066-2, INS 300, and food additive code E 300. The molecular formula is C₆H₈O₆ with a molecular weight of 176.12 g/mol. Commercial production uses the Reichstein process or fermentation-based conversion of D-sorbitol; the finished powder is crystallized, sieved, and blended to meet particle-size limits. Pharmacopoeial assay limits specify ascorbic acid content between 99.0% and 100.5% on the dried basis. Loss on drying by Ph. Eur. monograph 0253 limit is not more than 0.40%, residue on ignition is not more than 0.10%, and heavy metals do not exceed 10 mg/kg. The specific rotation for a 10% w/v aqueous solution at 25 °C falls within +20.5° to +21.5°. A 5% aqueous solution has a pH of 2.1–2.6. The crystalline powder is freely soluble in water at approximately 330 g/L at 25 °C and sparingly soluble in ethanol at approximately 20 g/L. Bulk density, measured by USP 616 Method I, is typically 0.70–0.90 g/cm³; particle-size distribution varies with milling, but direct-compression grades are commonly controlled to a D₅₀ between 200 µm and 350 µm. The product is packaged in sealed aluminium-foil-lined fibre drums with an inner polyethylene liner, and desiccant is required when relative humidity exceeds 60%.

For dry blending applications, the coarse crystalline morphology is preferred over fine powder because finer fractions below 100 µm increase dusting and electrostatic adhesion on vertical form-fill-seal equipment. Loss-in-weight feeders with screw speeds above 50 rpm deliver the crystalline grade with less inter-batch drift than fine powders. Milling to a D₅₀ below 150 µm is reserved for aqueous premixes that require rapid dissolution; the increased specific surface area shortens wetting time but accelerates hygroscopic caking if hopper relative humidity exceeds 50%.

What separates VC-100 from buffered ascorbate salts in aqueous systems?

Selection between VC-100 and sodium or calcium ascorbate is controlled by pH constraints and cation load. VC-100 lowers solution pH and contributes no sodium or calcium. Sodium ascorbate is preferred where pH depression is not tolerable; its 5% solution pH is 5.5–7.0, and it contributes approximately 11.3 g sodium per 100 g of compound. For equivalent ascorbate anion delivery, the mass correction factor of sodium ascorbate relative to VC-100 is 1.125. Calcium ascorbate dihydrate contributes approximately 10.6 g calcium per 100 g and is used in calcium-fortified dry blends. The redox activity of all three salts arises from the same ascorbate anion; however, dissociation and chelation behaviour differ. VC-100 is more aggressive toward tinplate and aluminium surfaces at low pH and requires 316L stainless-steel or high-density polyethylene transfer lines. In beverage premixes, VC-100 is chosen when the final formula contains added acidulants; sodium ascorbate is substituted when the formula must remain above pH 5.0 to avoid protein flocculation.

Regulatory compliance is documented against USP NF, Ph. Eur. monograph 0253, FCC 12, and JECFA 2021. Under 21 CFR 182.5013, ascorbic acid is generally recognized as safe for use in food. In the European Union it is listed as E 300 under Regulation (EC) No 1333/2008. For meat and poultry applications, 9 CFR 424.21 permits ascorbic acid or sodium ascorbate at 550 mg/kg in pumped bacon. Each certificate of analysis lists assay, optical rotation, loss on drying, residue on ignition, lead, arsenic, iron, copper, oxalate, and sulphate.

For lot release, redox titration with 2,6-dichloroindophenol according to AOAC 967.21 is used for assay confirmation; high-performance liquid chromatography with ultraviolet detection at 245 nm separates ascorbic acid from dehydroascorbic acid. Identity is confirmed by Fourier-transform infrared spectroscopy with attenuated total reflectance against a USP reference standard and by the specific rotation method. Residual solvent, sulphate ash, and oxalate tests are included when the product is intended for pharmaceutical excipient use. Insoluble matter is controlled below 0.05% for parenteral grades.

Dosing windows in beverage and meat-curing lines are constrained by redox potential, not pH alone

In fruit and vegetable juice lines, VC-100 is added at 50–150 mg/L before deaeration and pasteurization to scavenge residual dissolved oxygen. The effect is concentration-dependent; at dosing below 20 mg/L, colour loss in oxygen-sensitive anthocyanin systems remains detectable. High-temperature short-time plate pasteurizers running at 95 °C for 15 s reduce microbial load but accelerate oxidative loss of ascorbic acid by Fenton-type pathways when copper or iron is present above 0.05 mg/L in source water. Beverage preparation therefore requires chelation with citric acid or tetrasodium EDTA and oxygen levels below 0.5 mg/L before dosing. In fortified still beverages, an overage of 10–25% is added to compensate for thermal loss during tunnel pasteurization at 85–90 °C. Dry powdered beverage premixes are blended with glucose or maltodextrin as carriers, and ascorbic acid is added after drying to avoid early degradation in high-moisture agglomerates. In pumped bacon and cured meat operations, VC-100 is blended at 550 mg/kg under 9 CFR 424.21 with sodium nitrite to accelerate nitrite reduction to nitric oxide and stabilize cured colour. Production-scale tumbler injection lines require the ascorbic acid to be pre-dissolved in chilled water at 4 °C to avoid premature nitrite loss.

In wheat flour fortification and frozen dough systems, VC-100 is dispersed at 25–100 mg/kg flour. The reducing action strengthens gluten networks by preserving free sulfhydryl groups; dough extensibility measured by farinograph changes by less than 5% when VC-100 is kept below 100 mg/kg. Above 200 mg/kg, yeast activity in lean formulations can be inhibited by acidification of the aqueous dough phase. Ribbon blenders with spray-bar addition are used to introduce VC-100 as a 5–10% aqueous solution immediately before dough mixing; dry addition in flour silos leads to stratification and variable loaf volume across shifts.

Direct-compression premixes containing VC-100 are processed on rotary tablet presses at 400,000–600,000 tablets/h. Low moisture is critical; powder conditioned above 60% relative humidity forms agglomerates and sticks to punch faces. Formulators blend VC-100 with microcrystalline cellulose and magnesium stearate at 0.5–1.0% w/w. Ascorbic acid is an acidulant and can accelerate hydrolysis of acid-labile actives such as pantoprazole and atorvastatin; compatibility screening by differential scanning calorimetry and high-performance liquid chromatography is required before blending. In effervescent tablet lines, VC-100 is granulated with citric acid and sodium bicarbonate using a top-spray fluid-bed granulator with inlet air temperature 50–55 °C; higher inlet temperatures cause surface browning and carbon dioxide loss. Dissolution testing follows USP 711 apparatus 2 at 50 rpm, and disintegration follows USP 701. Parenteral formulations use VC-100 as an antioxidant in ampoules and vials at 0.01–1.0% w/v, with nitrogen sparging and amber borosilicate glass to limit photochemical degradation.

If the Application Requires Lipid-Phase Antioxidant Activity

VC-100 is not suitable for bulk oils, shortenings, or anhydrous lipid systems because it is insoluble in triacylglycerols and phase separates. Ascorbyl palmitate, with molecular weight 414.53 g/mol and an HLB of approximately 6, is the lipophilic ester used at 200 mg/kg in bulk oils. The hydroalcoholic solubility of VC-100 confines its antioxidant action to aqueous phases and oil–water interfaces in emulsions. In mayonnaise and dressing production, VC-100 is added to the aqueous phase at 0.05–0.20% w/w before emulsification to protect unsaturated fatty acids from oxidation; the ascorbate radical reduces tocopheroxyl radicals at the interface. Emulsion producers monitor peroxide value by AOCS Cd 8b-90 and p-anisidine value by AOCS Cd 18-90 to compare the activity of VC-100 with lipophilic alternatives. In fat-based cosmetic anhydrous balms, VC-100 is not used; instead, ascorbyl tetra-isopalmitate or ascorbyl palmitate is dissolved in the oil phase.

Cosmetic aqueous serums containing VC-100 are formulated at pH 3.0–3.5 because protonated ascorbic acid penetrates the stratum corneum more efficiently than the ascorbate anion. At pH above 5.0, oxidative browning accelerates and the product develops a yellow tint within 7–14 days at 25 °C in oxygen-permeable packaging. Packaging in airless pumps or multi-layer tubes with ethylene-vinyl alcohol barrier reduces headspace oxygen. Addition of ferulic acid at 0.5% w/w and tocopherol at 1.0% w/w stabilizes VC-100 in aqueous serum; the combination is supported by published stability data using ultraviolet spectrophotometry at 265 nm to track intact ascorbic acid. Accelerated storage at 40 °C and 75% relative humidity for 4 weeks is used as a screening condition before packaging qualification. Neutralization with triethanolamine produces triethanolamine ascorbate and raises pH above 5.0, reducing chemical stability.

Metal-catalysed oxidative degradation pathways and packaging barriers

The degradation of VC-100 in aqueous systems follows first-order kinetics after an induction period; the rate constant increases 2–5 fold in the presence of cupric ion at 0.1 mg/L. Copper and iron catalyse the reduction of molecular oxygen to superoxide and hydrogen peroxide, which then oxidize ascorbate to dehydroascorbic acid and further to 2,3-diketogulonic acid. The latter pathway is irreversible and cannot be reversed by reducing agents in the finished product. To minimise catalytic loss, stainless-steel contact surfaces should be 316L electropolished, and distribution piping should avoid brass, bronze, or copper. Where copper cannot be eliminated, tetrasodium EDTA at 0.01–0.05% w/w chelates free copper and reduces degradation. Dry VC-100 is more stable than aqueous solutions; however, at relative humidity above 60%, capillary condensation on crystal surfaces initiates surface browning. Warehouses should maintain 18–25 °C and 35–55% relative humidity, and inventory should be rotated within 24 months in unopened original packaging. The product is incompatible with alkali carbonates, strong oxidizers, copper salts, iron salts, and amines; dry blending with sodium bicarbonate without moisture control initiates premature effervescence and browning.